Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Dealing with diagnostic bias and uncertainty: What is the burden of proof in toxicology?
Journal: Clinical toxicology (Philadelphia, Pa.)
Published: July 23, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Journal: American journal of hematology
Published: January 05, 2026
Pacritinib in patients with myelodysplastic/myeloproliferative neoplasms.
Journal: Leukemia & lymphoma
Published: November 26, 2025
Leukemia cutis and all-trans retinoic acid-induced myocarditis in acute promyelocytic leukemia.
Journal: Clinical hematology international
Published: November 11, 2025
Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experience.
Journal: Frontiers in immunology
Published: October 09, 2025
What's new in critical illness and injury science? Pediatric poison prevention - No more "accidents".
Journal: International journal of critical illness and injury science
Published: September 19, 2025
Biostatistics and Epidemiology for the Toxicologist: Miscellaneous Bias - Confirmation, Non-Response, Survivorship, and Selection.
Journal: Journal of medical toxicology : official journal of the American College of Medical Toxicology
Published: May 13, 2025
New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 07, 2025
Last Updated: 09/26/2026